AANS Beyond 2021: Trauma Bundle-VTE Prophylaxis: Clinal Practice Guidlines

Video Transcription

Video Summary

In this video, Dr. Ryan Kitagawa, the Director of Neurotrauma for UT Houston and Memorial Hermann Hospital, discusses venous thromboembolism (VTE) prophylaxis and its clinical practices and guidelines. He shares his experience and insights on the use of chemoprophylaxis, specifically sub-q heparin and low molecular weight heparin, in different patient populations such as traumatic brain injury patients, post-surgical patients, and those at risk for DVTs and PEs. Dr. Kitagawa emphasizes the importance of assessing the risk factors and timing for starting chemoprophylaxis and suggests a rational approach based on the patient's individual condition. He also discusses the use of aspirin and anticoagulants such as IV heparin in patients with traumatic intracranial hemorrhage, highlighting the evolving perception of their safety. Dr. Kitagawa concludes by presenting his protocol and recommendations for starting and managing chemoprophylaxis and anticoagulation in patients at different risk levels.

Keywords

venous thromboembolism prophylaxis

chemoprophylaxis

patient populations

risk factors

anticoagulants

protocol